Mutations in the NADPH oxidase DUOX2 and, to a lesser extent, DUOX1 have been associated with dyshormonogenesis in CH patients (Aycan et al., 2017; Moreno et al., 2002). This evidence concerns the gene DUOX1 and cyclic hematopoiesis.